The first study to compare accident rates for drivers who have advanced glaucoma − an eye disease that affects peripheral vision − with normal-vision drivers, found that the glaucoma group had about twice as many accidents.
This study, which was conducted in Japan using a driving simulator, suggests that potential drivers should pass a visual field test to ensure adequate peripheral vision before a license is granted or renewed. The research is being presented today at the 116th Annual Meeting of the American Academy of Ophthalmology, jointly conducted this year with the Asia-Pacific Academy of Ophthalmology.
Glaucoma, which is an age-related eye disease, can partially or severely restrict a person's peripheral vision, without damaging their central vision or visual acuity. (Click here to see how glaucoma can affect vision.) This means that many people who have the disease would be able to pass the only vision test now required for a driver's license in most countries, known as the visual acuity test. Drivers need good peripheral vision in order to assess and keep up with the flow of traffic, stay in the proper lane, and detect stop lights, pedestrians, vehicles and other obstacles.
In this study, which was conducted at Tohoku University Graduate School of Medicine, in Sendai, Japan, two groups of 36 people each were tested using a driving simulator. People in group one had advanced glaucoma and those in group two had normal vision. The groups were matched for age, driving experience and other characteristics. The most common accident scenario for both the glaucoma and normal-vision groups was when a child, car, or other object suddenly entered the driver's path from the side. The glaucoma group, however, had more than twice as many collisions as the normal-vision group.
Glaucoma affects more than 2.7 million Americans age 40 and older. It is the second leading cause of blindness worldwide. If untreated, glaucoma reduces peripheral vision and eventually causes blindness by damaging the optic nerve. This essential nerve sends signals from the retina — a layer of light-sensitive tissue at the back of the eye — to the brain, where these signals are interpreted as the images people see. Only half of the people who have glaucoma are aware of it , since the disease is painless and vision loss is very gradual.
As populations grow older worldwide, health officials are exploring measures that will ensure safety on the roads. For instance, in the United States., visual field requirements vary from state to state with 12 of the 51 jurisdictions restricting licenses for those with visual impairments. Some states or territories require the installation of additional mirrors on the vehicles of these drivers.
"To help ensure everyone's safety on our roadways, we would like to create mandatory vision testing guidelines for glaucoma patients," said Shiho Kunimatsu-Sanuki, M.D., lead researcher on the study. "We now know that integrating the visual field test into the requirements for a driver's license could save lives."
With proper medical care, many people with glaucoma can maintain a level of vision that would enable safe driving. The American Academy of Ophthalmology recommends that everyone have a complete eye exam at age 40, so that glaucoma and other age-related eye diseases can be diagnosed and treated early to minimize vision loss.
The 116th Annual Meeting of the American Academy of Ophthalmology is in session November 10-13 at McCormick Place in Chicago. It is the world's largest, most comprehensive ophthalmic education conference. More than 25,000 attendees and 500 companies gather each year to showcase the latest in ophthalmic education, research, clinical developments, technology, products and services. This year's meeting is being held in partnership with the Asia-Pacific Academy of Ophthalmology. To learn more about the place Where All of Ophthalmology Meets, visit http://www.aao.org/meetings/annual_meeting/
Note to media: Contact Media Relations to request full text of the study and arrange interviews with experts
About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons — Eye M.D.s— with more than 32,000 members worldwide. Eye health care is provided by the three "O's" – ophthalmologists, optometrists, and opticians. It is the ophthalmologist, or Eye M.D., who can treat it all: eye diseases, infections and injuries, and perform eye surgery. For more information, visit www.aao.org The Academy's EyeSmart® program educates the public about the importance of eye health and empowers them to preserve healthy vision. EyeSmart provides the most trusted and medically accurate information about eye diseases, conditions and injuries. OjosSanos™ is the Spanish-language version of the program. Visit www.geteyesmart.org or www.ojossanos.org to learn more.
Mary Wade | EurekAlert!
Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland
Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy